Biogen | BIIB - Eps Gewinn Pro Aktie

Aktienkurs
184.38
Täglich Wechseln
-3.50 -1.86%
Monatlich
-2.54%
Jährlich
55.15%
Q2 Prognose
180.43

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 3.06 3.02 May/06
FY2025Q4 Dec/2025 1.99 1.74 3.44 Feb/06
FY2025Q3 Sep/2025 4.81 3.84 4.08 Oct/30
FY2025Q2 Jun/2025 5.47 4.08 5.28 Jul/31
FY2025Q1 Mar/2025 3.02 3.96 3.67 May/01




Eps Veränderung Datum
AbbVie USD 2.71 0.85 2025-12
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
ALKERMES USD 0.29 0.2 2025-12
Amgen USD 5.29 0.35 2025-12
Bayer EUR 0.62 0.05 2025-12
Biogen USD 1.99 2.82 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Esperion Therapeutics USD 0.26 0.42 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
Incyte USD 1.8 0.46 2025-12
Merck USD 2.04 0.54 2025-12
Moderna USD -2.11 1.6 2025-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
Novartis USD 1.54 0.5 2025-12
Pfizer USD 0.66 0.21 2025-12
PTC Therapeutics USD -1.67 1.87 2025-12
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 1.88 0.35 2026-03
Sanofi EUR 2.17 2.84 2026-03
Sarepta Therapeutics USD -3.58 3.45 2025-12
Teva Pharmaceutical Industries USD 2.98 0.43 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
United Therapeutics USD 7.7 0.54 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12